Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TAXOTERE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 389 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ciccolini, J; Catalin, J; Blachon, MF; Durand, A
      Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction

      JOURNAL OF CHROMATOGRAPHY B
    2. Gueritte, F
      General and recent aspects of the chemistry and structure-activity relationships of taxoids

      CURRENT PHARMACEUTICAL DESIGN
    3. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    4. Nishizaki, M; Meyn, RE; Levy, LB; Atkinson, EN; White, RA; Roth, JA; Ji, L
      Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo

      CLINICAL CANCER RESEARCH
    5. Rose, WC; Long, BH; Fairchild, CR; Lee, FYF; Kadow, JF
      Preclinical pharmacology of BMS-275183, an orally active taxane

      CLINICAL CANCER RESEARCH
    6. Kaye, SB
      The integration of docetaxel into first-line chemotherapy for ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    7. Calderoni, A; Cerny, T
      Taxanes in lung cancer: a review with focus on the European experience

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    8. Mason, K; Staab, A; Hunter, N; McBride, W; Petersen, S; Terry, N; Milas, L
      Enhancement of tumor radioresponse by docetaxel: Involvement of immune system

      INTERNATIONAL JOURNAL OF ONCOLOGY
    9. Sternberg, CN
      Systemic treatment and new developments in advanced prostate cancer

      EUROPEAN JOURNAL OF CANCER
    10. Takeda, Y; Yoshizaki, I; Nonaka, Y; Yanagie, H; Matsuzawa, A; Eriguchi, M
      Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo

      ANTI-CANCER DRUGS
    11. Small, EJ
      Docetaxel in prostate cancer

      ANTI-CANCER DRUGS
    12. Posner, MR
      Docetaxel in squamous cell cancer of the head and neck

      ANTI-CANCER DRUGS
    13. Beer, TM; Pierce, WC; Lowe, BA; Henner, WD
      Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer

      ANNALS OF ONCOLOGY
    14. Marti, JL; Bueso, P; Mayordomo, JI; Isla, MD; Saenz, A; Escudero, P; Murillo, L; Filipovich, E; Andres, R; Tres, A
      Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines

      ANNALS OF ONCOLOGY
    15. Campone, M; Fumoleau, P; Delecroix, V; Deporte-Fety, R; Perrocheau, G; Vernillet, L; Borg-Olivier, O; Louboutin, JP; Bissery, MC; Riva, A; Azli, N
      Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

      ANNALS OF ONCOLOGY
    16. Kornblith, AB; Herndon, JE; Zuckerman, E; Godley, PA; Savarese, D; Vogelzang, NJ; Holland, JC
      The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study

      ANNALS OF ONCOLOGY
    17. Crivellari, D; Pagani, O; Veronesi, A; Lombardi, D; Nole, F; Thurlimann, B; Hess, D; Borner, M; Bauer, J; Martinelli, G; Graffeo, R; Sessa, C; Goldhirsch, A
      High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

      ANNALS OF ONCOLOGY
    18. Plunkett, TA; Hanby, AM; Miles, DW; Rubens, RD
      Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy

      ANNALS OF ONCOLOGY
    19. Stemmler, HJ; Gutschow, K; Sommer, H; Malekmohammadi, M; Kentenich, C; Forstpointner, R; Geuenich, S; Bischoff, J; Hiddemann, W; Heinemann, V
      Weekly docetaxel (Taxotere (R)) in patients with metastatic breast cancer

      ANNALS OF ONCOLOGY
    20. Hamilton, A; Muggia, F
      Estramustine potentiates taxane in prostate and refractory breast cancers

      ONCOLOGY-NEW YORK
    21. Georgoulias, VA
      Docetaxel/gemcitabine: Salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer

      ONCOLOGY-NEW YORK
    22. Savarese, DM; Halabi, S; Hars, V; Akerley, WL; Taplin, ME; Godley, PA; Hussain, A; Small, EJ; Vogelzang, NJ
      Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780

      JOURNAL OF CLINICAL ONCOLOGY
    23. Hassett, G; Harnett, P; Manolios, N
      Scleroderma in association with the use of docetaxel (taxotere) for breastcancer

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    24. Ohe, Y; Niho, S; Kakinuma, R; Kubota, K; Matsumoto, T; Ohmatsu, H; Goto, K; Kunitoh, H; Saijo, N; Nishiwaki, Y
      Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    25. Bhargava, P; Marshall, JL; Fried, K; Williams, M; Lefebvre, P; Dahut, W; Hanfelt, J; Gehan, E; Figuera, M; Hawkins, MJ; Rizvi, NA
      Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    26. Rose, WC; Fairchild, C; Lee, FYF
      Preclinical antitumor activity of two novel taxanes

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    27. Schmidinger, M; Budinsky, AC; Wenzel, C; Locker, GJ; Pluschnig, U; Brodowicz, T; Kubista, E; Maca, S; Zabernigg, A; Ilsinger, P; Seewann, L; Hojas, S; Blach, M; Zielinski, CC; Steger, GG
      Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    28. Lanzi, C; Cassinelli, G; Cuccuru, G; Supino, R; Zuco, V; Ferlini, C; Scambia, G; Zunino, F
      Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells

      PROSTATE
    29. Avramis, IA; Kwock, R; Avramis, VI
      Taxotere and vincristine inhibit the secretion of the angiogenesis-inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistanthuman leukemia T-cell lines

      ANTICANCER RESEARCH
    30. Kubota, T; Egawa, T; Furukawa, T; Otani, Y; Watanabe, M; Furukawa, T; Kumai, K
      Docetaxel enhances the cytotoxicity of tetrahydropyranyladriamycin in a sequence-dependent manner

      ANTICANCER RESEARCH
    31. Agiostratidou, G; Sgouros, I; Galani, E; Voulgari, A; Chondrogianni, N; Samantas, E; Dimopoulos, MA; Skarlos, D; Gonos, ES
      Correlation of in vitro cytotoxicity and clinical response to chemotherapyin ovarian and breast cancer patients

      ANTICANCER RESEARCH
    32. Leu, KM; Kim, KM; Larson, M; Larson, M; Schiller, JH
      Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy

      LUNG CANCER
    33. Koizumi, T; Tsunoda, T; Fujimoto, K; Nomura, H; Hirai, K; Koyama, S; Okada, K; Kubo, K
      Phase I trial of weekly docetaxel combined with cisplatin in patients withnon-small cell lung cancer

      LUNG CANCER
    34. Bruno, R; Vivier, N; Veyrat-Follet, C; Montay, G; Rhodes, GR
      Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel

      INVESTIGATIONAL NEW DRUGS
    35. Zanotti, KM; Markman, M
      Prevention and management of antineoplastic-induced hypersensitivity reactions

      DRUG SAFETY
    36. Pienta, KJ
      Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer

      SEMINARS IN ONCOLOGY
    37. Copur, MS; Ledakis, P; Lynch, J; Hauke, R; Tarantolo, S; Bolton, M; Norvell, M; Muhvic, J; Hake, L; Wendt, J
      Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer

      SEMINARS IN ONCOLOGY
    38. Hussain, A; Dawson, N; Amin, P; Naslund, M; Engstrom, C; Chen, T
      Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: Preliminary results

      SEMINARS IN ONCOLOGY
    39. Ryan, CW; Stadler, WM; Vogelzang, NJ
      Docetaxel and exisulind in hormone-refractory prostate cancer

      SEMINARS IN ONCOLOGY
    40. Fang, WS; Fang, QC; Liang, XT
      Synthesis of the 2 alpha-benzoylamido analogue of docetaxel

      TETRAHEDRON LETTERS
    41. Liu, B; Staren, ED; Iwamura, T; Appert, HE; Howard, JM
      Mechanisms of taxotere-related drug resistance in pancreatic carcinoma

      JOURNAL OF SURGICAL RESEARCH
    42. Pradier, O; Rave-Frank, M; Lehmann, J; Lucke, E; Boghun, O; Hess, CF; Schmidberger, H
      Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki)

      INTERNATIONAL JOURNAL OF CANCER
    43. Granda, TG; Filipski, E; D'Attino, RM; Vrignaud, P; Anjo, A; Bissery, MC; Levi, F
      Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination

      CANCER RESEARCH
    44. Ahmadi, MA; Esmaeli, B
      Surgical treatment of canalicular stenosis in patients receiving docetaxelweekly

      ARCHIVES OF OPHTHALMOLOGY
    45. Bourgeois, D; Prunet, J; Pancrazi, A; Prange, T; Lallemand, JY
      Alkyne zip reaction in the synthesis of a taxoid C-ring

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    46. Garg, MB; Ackland, SP
      Simple and sensitive high-performance liquid chromatography method for thedetermination of docetaxel in human plasma or urine

      JOURNAL OF CHROMATOGRAPHY B
    47. Rosenblum, MD; Shivers, RR
      'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    48. Comer, AM; Goa, KL
      Docetaxel - A review of its use in non-small cell lung cancer

      DRUGS & AGING
    49. Hirth, J; Watkins, PB; Strawderman, M; Schott, A; Bruno, R; Baker, LH
      The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance

      CLINICAL CANCER RESEARCH
    50. van Zuylen, L; Sparreboom, A; van der Gaast, A; van der Burg, MEL; van Beurden, V; Bol, CJ; Woestenborghs, R; Palmer, PA; Verweij, J
      The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel

      CLINICAL CANCER RESEARCH
    51. Van den Neste, E; de Valeriola, D; Kerger, J; Bleiberg, H; Kusenda, Z; Brassinne, C; Bartholomeus, S; Selleslags, J; Hennebert, P; Wythouck, H; Cazenave, I; Lefresne-Soulas, F; Piccart, M
      A Phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors

      CLINICAL CANCER RESEARCH
    52. Kaye, SB
      Intravenous chemotherapy for ovarian cancer - the state of the art?

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    53. Matsuura, M; Hasegawa, M; Hayakawa, K; Kawashima, M; Nasu, S; Nakamura, Y; Hayakawa, K; Mitsuhashi, N; Niibe, H
      Experimental study of the effects on apoptosis of docetaxel alone and in combination with irradiation

      ONCOLOGY REPORTS
    54. De Santis, M; Lucchese, A; De Carolis, S; Ferrazzani, S; Caruso, A
      Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel

      EUROPEAN JOURNAL OF CANCER CARE
    55. Rougier, P; Adenis, A; Ducreux, M; de Forni, M; Bonneterre, J; Dembak, M; Clouet, P; Lebecq, A; Baille, P; Lefresne-Soulas, F; Blanc, C; Armand, JP
      A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

      EUROPEAN JOURNAL OF CANCER
    56. Lortholary, A; Maillard, P; Delva, R; Boisdron-Celle, M; Perard, D; Vernillet, L; Besenval, M; Gamelin, E
      Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study

      EUROPEAN JOURNAL OF CANCER
    57. Lin, YC; Chang, HK; Wang, CH; Chen, JS; Liaw, CC
      Single-agent docetaxel in metastatic breast cancer patients pre-treated with anthracyclines and paclitaxel: partial cross-resistance between paclitaxel and docetaxel

      ANTI-CANCER DRUGS
    58. Suzuma, T; Sakurai, T; Yoshimura, G; Umemura, T; Tamaki, T; Naito, Y
      Paclitaxel-induced remission in docetaxel-refractory anthracycline-pretreated metastatic breast cancer

      ANTI-CANCER DRUGS
    59. Kruijtzer, CMF; Verweij, J; Schellens, JHM; Beijnen, JH; Pronk, L; Bo, M; Lustig, V; van Tinteren, H; Mackay, M; Huinink, WWT
      Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: Results of a compassionate use program inThe Netherlands

      ANTI-CANCER DRUGS
    60. Ollikainen, T; Knuuttila, A; Suhonen, S; Taavitsainen, M; Jekunen, A; Mattson, K; Linnainmaa, K
      In vitro sensitivity of normal human mesothelial and malignant mesothelioma cell lines to four new chemotherapeutic agents

      ANTI-CANCER DRUGS
    61. Wuts, PGM; Gu, RL; Northuis, JM
      Synthesis of (2R,3S)-isobutyl phenylisoserinate, the Taxol (R) side chain,from ethyl benzoylacetate

      TETRAHEDRON-ASYMMETRY
    62. Bourgeois, D; Maiti, G; Pancrazi, A; Prunet, J
      Diastereoselective additions of nucleophiles to hindered alpha-trimethylsilyloxy aldehydes

      SYNLETT
    63. Coleman, RE; Howell, A; Eggleton, SPH; Maling, SJ; Miles, DW
      Phase II study of docetaxel in patients with liver metastases from breast cancer

      ANNALS OF ONCOLOGY
    64. Katsumata, N; Tsunematsu, R; Tanaka, K; Terashima, Y; Ogita, S; Hoshiai, H; Kohno, I; Hirabayashi, K; Yakushiji, M; Noda, K; Taguchi, T
      A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: A Japanese Cooperative Study

      ANNALS OF ONCOLOGY
    65. Small, EJ
      Management of advanced/metastatic prostate cancer: 2000 update - The Hussain/Dawson article reviewed

      ONCOLOGY-NEW YORK
    66. Adjei, AA; Klein, CE; Kastrissios, H; Goldberg, RM; Alberts, SR; Pitot, HC; Sloan, JA; Reid, JM; Hanson, LJ; Atherton, P; Rubin, J; Erlichman, C
      Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: Preliminary evidence of clinical activity

      JOURNAL OF CLINICAL ONCOLOGY
    67. Huisman, C; Smit, EF; Giaccone, G; Postmus, PE
      Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: A review

      JOURNAL OF CLINICAL ONCOLOGY
    68. Couteau, C; Risse, ML; Ducreux, M; Lefresne-Soulas, F; Riva, A; Lebecq, A; Ruffie, P; Rougier, P; Lokiec, F; Bruno, R; Armand, JP
      Phase I and pharmacokinetic study of docetaxel and irinotecan in patients with advanced solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    69. Kurata, T; Shimada, Y; Tamura, T; Yamamoto, N; Hyodo, I; Saeki, T; Takashima, S; Fujiwara, K; Wakasugi, H; Kashimura, M
      Phase I and pharmacokinetic study of a new taxoid, RPR 109881A, given as a1-hour intravenous infusion in patients with advanced solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    70. Masuda, N; Negoro, S; Kudoh, S; Sugiura, T; Nakagawa, K; Saka, H; Takada, M; Niitani, H; Fukuoka, M
      Phase I and pharmacologic study of docetaxel and irinotecan in advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    71. Verschraegen, CF; Sittisomwong, T; Kudelka, AP; Guedes, ED; Steger, M; Nelson-Taylor, T; Vincent, M; Rogers, R; Atkinson, EN; Kavanagh, JJ
      Docetaxel for patients with paclitaxel-resistant mullerian carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    72. Yamamoto, N; Tamura, T; Kamiya, Y; Sekine, I; Kunitoh, H; Saijo, N
      Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol

      JOURNAL OF CLINICAL ONCOLOGY
    73. Iimura, S; Ohsuki, S; Chiba, J; Uoto, K; Iwahana, M; Terasawa, H; Soga, T
      Synthesis and antitumor activity of non-prodrug water-soluble taxoid: 10-C-aminoalkylated docetaxel analogs

      HETEROCYCLES
    74. Cheng, Q; Horiguchi, T; Yamaguchi, M; Oritani, T
      High regio- and stereoselectivity in facile one-pot conversion of taxoids to the primary alcohols: Precursors for the synthesis of 4-deacetoxypacilitaxel and analogues

      HETEROCYCLES
    75. Bellon, JR; Lindsley, KL; Ellis, GK; Gralow, JR; Livingston, RB; Seymour, MMA
      Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-rise breast cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    76. Yang, LX; Wang, HJ; Holton, RA
      In vitro efficacy of a novel chemoradiopotentiator - Taxoltere metro

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    77. Tkaczuk, KH; Zamboni, WC; Tait, NS; Meisenberg, BR; Doyle, LA; Edelman, MJ; Hausner, PF; Egorin, MJ; Van Echo, DA
      Phase I study of docetaxel and topotecan in patients with solid tumors

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    78. Rosing, H; Lustig, V; van Warmerdam, LJC; Huizing, MT; Huinink, WWT; Schellens, JHM; Rodenhuis, S; Bult, A; Beijnen, JH
      Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    79. Chan, OTM; Yang, LX
      The immunological effects of taxanes

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    80. Goh, BC; Lehnert, M; Lim, HL; Ng, AWK; Chan, CC; Kong, HL; Lee, SC; Wee, J; Chua, ET; Wong, JEL
      Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer

      ACTA ONCOLOGICA
    81. Schrijvers, D; Pronk, L; Highley, M; Bruno, R; Locci-Tonelli, D; De Bruijn, E; Van Oosterom, AT; Verweij, J
      Pharmacokinetics of ifosfamide are changed by combination with docetaxel -Results of a phase I pharmacologic study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    82. Janinis, J; Papadakou, M; Xidakis, E; Boukis, H; Poulis, A; Panagos, G; Lefantzis, D
      Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer - A phase II feasibility study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    83. Ferraresi, V; Milella, M; Vaccaro, A; D'Ottavio, AM; Papaldo, P; Nistico, C; Thorel, MF; Marsella, A; Carpino, A; Giannarelli, D; Terzoli, E; Cognetti, F
      Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients - A phase II study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    84. Beer, T; Raghavan, D
      Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder

      PROSTATE
    85. Williams, JF; Muenchen, HJ; Kamradt, JM; Korenchuk, S; Pienta, KJ
      Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: An experimental study

      PROSTATE
    86. Shi, BX; Liang, SL; Yuan, YJ; Sun, M; Miao, FM
      Studies on the quantitative structure-activity relationships of paclitaxelanalogues

      CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE
    87. Shin, E; Ishitobi, M; Hiraoia, M; Kazumasa, F; Hideyuki, M; Nishisho, I; Toshiro, S; Yasunori, H; Tosimasa, T
      Phase I study of docetaxel administered by bi-weekly infusion to patients with metastatic breast cancer

      ANTICANCER RESEARCH
    88. Hashiyama, T
      Applications of Lewis acids for the efficient syntheses of diltiazem, cephems, and taxoids

      MEDICINAL RESEARCH REVIEWS
    89. Langer, CJ
      Advanced non-small cell lung carcinoma: The emerging role of docetaxel

      INVESTIGATIONAL NEW DRUGS
    90. Sanson, M; Napolitano, M; Yaya, R; Keime-Guibert, F; Broet, P; Hoang-Xuan, K; Delattre, JY
      Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study

      JOURNAL OF NEURO-ONCOLOGY
    91. Kreis, W; Petrylak, D; Savarese, D; Budman, D
      Colitis and docetaxel-based chemotherapy

      LANCET
    92. Khuri, FR; Shin, DM; Glisson, BS; Lippman, SM; Hong, WK
      Treatment of patients with recurrent or metastatic squamous cell carcinomaof the head and neck: Current status and future directions

      SEMINARS IN ONCOLOGY
    93. Myers, AG; Zhong, BY; Movassaghi, M; Kung, DW; Lanman, BA; Kwon, S
      Synthesis of highly epimerizable N-protected alpha-amino aldehydes of highenantiomeric excess

      TETRAHEDRON LETTERS
    94. Horiguchi, T; Cheng, Q; Oritani, T
      Highly regio- and stereospecific hydroxylation of C-1 position of 2-deacetoxytaxinine J derivative with DMDO

      TETRAHEDRON LETTERS
    95. Bourgeois, D; Mahuteau, J; Pancrazi, A; Nolan, SP; Prunet, J
      Synthesis of BC ring-systems of Taxol by ring-closing metathesis

      SYNTHESIS-STUTTGART
    96. Borek-Dohalska, L; Gut, I; Soucek, P; Roth, Z; Hodek, P
      Cytochromes P450 involved in cyclophosphamide, paclitaxel and docetaxel metabolism in rats

      COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS
    97. Borek-Dohalska, L; Stiborova, M
      Texanes - Anticancer drug with unique mechanism of action

      CHEMICKE LISTY
    98. Smith, MR; Kaufman, D; Oh, W; Guerin, K; Seiden, M; Makatsoris, T; Manola, J; Kantoff, PW
      Vinorelbine and estramustine in androgen-independent metastatic prostate cancer - A phase II study

      CANCER
    99. Cleveland, MG; Ajaikumar, BS; Reganti, R
      Cutaneous fibrosis induced by docetaxel - A case report

      CANCER
    100. Hussain, S; Anderson, DN; Salvatti, ME; Adamson, B; McManus, M; Braverman, AS
      Onycholysis as a complication of systemic chemotherapy - Report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature

      CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 20:26:01